Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Model ligand-based

Test set (n) Receptor-based model Ligand-based model Interaction-energy model... [Pg.156]

Before discussing the AIM theory, we describe in Chapters 4 and 5 two simple models, the valence shell electron pair (VSEPR) model and the ligand close-packing (LCP) model of molecular geometry. These models are based on a simple qualitative picture of the electron distribution in a molecule, particularly as it influenced by the Pauli principle. [Pg.82]

This example is one where the accurate three-dimensional structure of the protein is unknown under these circumstances, it is necessary to create a computer model. The development of inhibitors that are designed to overcome the effects of this mutation could not be based on the accurate structure of a ligand-binding site here, ligand-based design would be appropriate (see Sect. 7.9). [Pg.147]

Figure 1.10 Preinsertion intermediates for secondary propene insertion into primary polypropylene chain for (a) isospecific model complex based on (R, R)-coordinatedisopropyl-bis(l-indenyl) ligand and (b) syndiospecific model complex based on isopropyl(cyclopentadienyl-9-fluorenyl) ligand for R chirality at metal atom. Stereoselectivity of isospecific model site is in favor of opposite monomer prochiral faces for primary and secondary insertions (cf. Figures 1.4 and 1.10a). Stereoselectivity of syndiospecific model site is in favor of same monomer prochiral face for primary and secondary insertions (cf. Figures 1.6a and 1.1 Ob). Figure 1.10 Preinsertion intermediates for secondary propene insertion into primary polypropylene chain for (a) isospecific model complex based on (R, R)-coordinatedisopropyl-bis(l-indenyl) ligand and (b) syndiospecific model complex based on isopropyl(cyclopentadienyl-9-fluorenyl) ligand for R chirality at metal atom. Stereoselectivity of isospecific model site is in favor of opposite monomer prochiral faces for primary and secondary insertions (cf. Figures 1.4 and 1.10a). Stereoselectivity of syndiospecific model site is in favor of same monomer prochiral face for primary and secondary insertions (cf. Figures 1.6a and 1.1 Ob).
The stereoselectivities in this reaction are governed by steric interactions in the formation of metallacyclobutane 60 (35). Of two possible intermediates (Fig. 5), 61 suffers from steric interactions between the ligand and the ester functionality. Avoidance of these interactions and minimization of 1,2-interaction in the metallacyclobutane leads to the formation of the observed major enantiomer and dias-tereomer (trans). The model suggests that increased diastereoselectivity should be observed with increasing steric bulk of the diazoester, a relationship that has already been established as discussed (cf. Eqs. 24 and 26). It is interesting to note that this model loosely corresponds to the stereochemical model proposed by Aratani for the Sumitomo cyclopropanation with one important difference the Aratani model is based on a tetrahedral metal while the Evans-Woerpel model is predicated on square-planar copper. Applying the Aratani model to the Evans ligand would predict formation of the opposite enantiomer as the major product (35). [Pg.23]

Andrus et al. (109) proposed a stereochemical rationale for the observed selec-tivities in this reaction. The model is based on the Beckwith modification (97) of the Kochi mechanism, suggesting that the stereochemistry-determining event is the ally lie transposition from Cu(III) allyl benzoate intermediates 152 and 153, Fig. 13. Andrus suggests that the key Cu(III) intermediate assumes a distorted square-planar geometry. Steric interactions are decreased between the ligand substituent and the cyclohexenyl group in Complex 152 as opposed to Complex 153 leading to the observed absolute stereochemistry. [Pg.58]

Ligand-Based Models for hERG-Blocking Activity... [Pg.110]


See other pages where Model ligand-based is mentioned: [Pg.116]    [Pg.183]    [Pg.358]    [Pg.116]    [Pg.183]    [Pg.358]    [Pg.296]    [Pg.352]    [Pg.352]    [Pg.354]    [Pg.359]    [Pg.361]    [Pg.364]    [Pg.114]    [Pg.1132]    [Pg.300]    [Pg.395]    [Pg.383]    [Pg.449]    [Pg.455]    [Pg.174]    [Pg.432]    [Pg.51]    [Pg.51]    [Pg.54]    [Pg.18]    [Pg.1]    [Pg.97]    [Pg.106]    [Pg.175]    [Pg.422]    [Pg.757]    [Pg.807]    [Pg.200]    [Pg.183]    [Pg.41]    [Pg.108]    [Pg.23]    [Pg.1318]    [Pg.496]    [Pg.22]    [Pg.100]    [Pg.100]    [Pg.110]    [Pg.110]   


SEARCH



Drug design structure, ligand-based models

Ligand model

Ligand-based

Ligand-based Pharmacophore Modeling

Ligands modeling

Molecular modeling pharmacophore-based ligand

Structure-based computational models of ligand-protein binding dynamics and molecular docking

Three-dimensional ligand-based models

Three-dimensional ligand-based models structure-activity relationships

Toxicity ligand based models

© 2024 chempedia.info